David Sher

@DavidSherMD

"Ultimately, the secret of quality is love. You have to love your patient, you to have to love your profession, you have to love your G-d." Avedis Donabedian

Dallas, TX

Joined April 2019

Replies Reposts Media

David Sher
@DavidSherMD
Aug 30
This paper is incredibly important. The authors asked a simple question: how reproducible is CTCAE v5.0 acute toxicity scoring during head and neck radiotherapy? It turns out that it’s not very reproducible. During a prospective clinical trial (specifics of the trial not
Shakthivelmani
@shakthivelmani
Aug 29
Documenting physician reported toxicities can vary between clinicians. This also raises the importance of documenting patient reported outcomes . A very pragmatic study done by TMH Head Neck Oncologist . Congratulations ! @RadOncTMC @shwetabhsinha23 @AnujkumarTvm
2
David Sher
@DavidSherMD
Aug 26
I now routinely perform PET-CT simulation for high-risk postop H&N cases and not uncommonly find residual (or progressive) FDG-avid disease. It makes me question whether the postop RT literature on intensification needs to be re-examined. How much is the benefit of chemotherapy,
11
David Sher
@DavidSherMD
Aug 23
The identification of the tubarial gland is a really cool story, though I am doubtful that TG-sparing radiotherapy will make a meaningful difference to patient-reported xerostomia. Sparing the contralateral TG should already effectively be part of standard practice for
Massimo
@Rainmaker1973
Aug 23
A new organ has been found behind your nose. For centuries, every anatomy textbook swore there were only three pairs of major salivary glands. Turns out the books were wrong, and the missing ones were hiding in plain sight. In 2020, Dutch researchers scanning head-and-neck
David Sher
@DavidSherMD
Aug 10
I think it is important to separate out fractionation from volume. The dominant, almost exclusive, pattern-of-failure for early-stage glottic larynx cancer is not just glottic, but in-field recurrence. This observation is the driver of vocal cord-only irradiation paradigms, which
Gabriel Lazcano
@gv_lazcano
Aug 9
Replying to @DavidSherMD and @I_Migowski
What do you think of moderate hypo fx? 55/20 is and accepted standard in the UK. At my center (South America) we are resource constrained, so anything doable with 3DCRT is a huge win.
David Sher
@DavidSherMD
Aug 5
Very cool case! 90 yo nursing home-bound gentleman with early-stage larynx cancer. Treated with 5 fractions and tolerated with minimal acute side effects (mild fatigue and dysphonia) and no longer-term sequelae thus far (7 months later). Left, today; right, pre-treatment.
3